Kodiak Sciences Inc (KOD) Fundamentals

Kodiak Sciences Inc is is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases.
SHARE INFORMATION
Market Cap$ 395,505,870
Shares Outstanding52,040,246
Float33,156,022
Percent Float63.71%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -5.16
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions427
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months5,404,245
Institutional Holdings Percent102.0%
Institutional Sold Previous 3 Months17,459,795
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months1,338,274
Insider Holdings Percent4.9
Insider Sold Previous 3 Months5,925
Insider Shares Owned2,562,669
TRADING INFO
52 Week High$ 131.97
52 Week Low$ 4.90
52 Week High Change$ -92.21
21 Day Moving Average$ 9.1324
21 Day Extended Moving Average$ 8.9429
50 Day Moving Average$ 9.9332
50 Day Extended Moving Average$ 9.4891
200 Day Moving Average$ 23.0998
200 Day Extended Moving Average$ 25.988
10 Day Average Volume575,754
20 Day Average Volume520,826
30 Day Average Volume475,747
50 Day Average Volume686,310
Alpha0.037335
Beta1.8625
Standard Deviation0.322938
R20.100645
7 Day Price Change$ -0.93
7 Day Percent Change-10.9%
21 Day Price Change$ -2.27
21 Day Percent Change-23.0%
30 Day Price Change$ -3.24
30 Day Percent Change-29.89%
Month to Date Price Change$ -2.41
Month to Date Percent Change-24.08%
Quarter to Date Price Change$ -0.04
Quarter to Date Percent Change-0.52%
180 Day Price Change$ -0.38
180 Day Percent Change-4.76%
200 Day Price Change$ -0.38
200 Day Percent Change-4.76%
Year to Date Price Change$ -77.18
Year to Date Percent Change-91.04%

Kodiak Sciences Inc (KOD) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.20
Int Coverage-16,524.10
Current Ratio8.70
Leverage Ratio1.40
Quick Ratio8.60
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio-1.20
Enterprise Value$ -92,443,423
Price to Sales0.00
Price to Free Cash-1.50
PE High Last 5 Years0.00
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-41.72
Return on Equity-56.90
Return on Capital-47.20

Kodiak Sciences Inc (KOD) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOVictor Perlroth
Emplyoees101
Last AuditUQ
CIK0001468748
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1200 Page Mill Road
Palo Alto, CA 94304
Websitehttps://www.kodiak.com
Facsimile-
Telephone+1 650 281-0850
EmailIR@kodiak.com


Your Recent History
NASDAQ
KOD
Kodiak Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.